Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.
Thank you. Please check your inbox to confirm.
STAT looked at Biden's COVID strategy and whether 2022 could finally be the year the pandemic fades into the background.
Facing an outbreak that is now among the largest in the country — and the focus of newfound concerns about a national resurgence of the measles — the Rockland County executive this week took a step seemingly without precedent in…
The apparent birth this month of the first genetically modified babies is “a lesson in the potential for human hubris to overtake us,” Dr. Francis Collins, the director of the National Institutes of Health.
If Republicans prevail in just two races on Tuesday, the Senate’s ranks would suddenly include two former drug industry lobbyists and a pharma CEO.
Two of the three largest distributors are on pace to exceed their campaign donations from 2016 — a notable increase.
The Senate is likely to pass a comprehensive bill to address the opioid crisis in the coming weeks. But the finish line on that long-discussed priority remains a long way off.
Federal agencies on Thursday announced charges in what Attorney General Jeff Sessions called “the largest health care fraud takedown in American history,” an investigation into over $2 billion in alleged fraud by doctors, pharmacists, and nurses.
Late last year Oxitec debuted its first “mobile production unit” — a miniature factory designed to help expand its reach.
Here are three 2018 campaigns to watch to determine what American voters make of how health care policy is being shaped in Washington.
The rally was a demonstration of enthusiasm and political clout. But organizers now hope to turn a march into a movement.
Support Provided By: